{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:33:36Z","timestamp":1787754816283,"version":"build-2784847793"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although ketamine shows a rapid and sustained antidepressant effect, the precise mechanisms underlying its effect are unknown. Recent studies indicate a key role of p11 (also known as S100A10) in depression-like behavior in rodents. The present study aimed to investigate the role of p11 in the antidepressant-like action of ketamine in chronic unpredictable mild stress (CUMS) rat model. The open-field test, forced swimming test and sucrose preference test were performed after administration of ketamine (10\u2009mg\u2009kg<jats:sup>\u22121<\/jats:sup>) or a combination of ketamine and ANA-12 (a tropomyosin-related kinase B (TrkB) antagonist; 0.5\u2009mg\u2009kg<jats:sup>\u22121<\/jats:sup>). The lentivirus vector for p11 was constructed to knock down the hippocampal expression of p11. In the CUMS rats, ketamine showed a rapid (0.5\u2009h) and sustained (72\u2009h) antidepressant effect, and its effect was significantly blocked by co-administration of ANA-12. Furthermore, ketamine significantly increased the reduced expression of brain-derived neurotrophic factor (BDNF) in the hippocampus of CUMS rats, whereas ketamine did not affect the expression of p11 in CUMS rats 0.5\u2009h after administration. In addition, ketamine significantly increased the reduced ratio of p-TrkB\/TrkB in the hippocampus by CUMS rats, and its effect was also blocked by ANA-12. Moreover, the reduced expression of BDNF and p11 in the hippocampus of CUMS rats was significantly recovered to control levels 72\u2009h after ketamine administration. Interestingly, knockdown of hippocampal p11 caused increased immobility time and decreased sucrose preference, which were not improved by ketamine administration. These results suggest that p11 in the hippocampus may have a key role in the sustained antidepressant effect of ketamine in the CUMS model of depression.<\/jats:p>","DOI":"10.1038\/tp.2016.21","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T15:11:33Z","timestamp":1456240293000},"page":"e741-e741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model"],"prefix":"10.1038","volume":"6","author":[{"given":"H-L","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z-Q","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G-F","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X-M","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-C","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-J","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,23]]},"reference":[{"key":"BFtp201621_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/35072566","volume":"2","author":"ML Wong","year":"2001","unstructured":"Wong ML, Licinio J . Research and treatment approaches to depression. Nat Rev Neurosci 2001; 2: 343\u2013551.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp201621_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","volume":"34","author":"EJ Nestler","year":"2002","unstructured":"Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM . Neurobiology of depression. Neuron 2002; 34: 13\u201325.","journal-title":"Neuron"},{"key":"BFtp201621_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1017\/S0033291702006943","volume":"33","author":"JT Cavanagh","year":"2003","unstructured":"Cavanagh JT, Carson AJ, Sharpe M, Lawrie SM . Psychological autopsy studies of suicide: a systematic review. Psychol Med 2003; 33: 395\u2013405.","journal-title":"Psychol Med"},{"key":"BFtp201621_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrn1846","volume":"7","author":"O Berton","year":"2006","unstructured":"Berton O, Nestler EJ . New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006; 7: 137\u2013151.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp201621_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/87865","volume":"7","author":"HK Manji","year":"2011","unstructured":"Manji HK, Drevets WC, Charney DS . The cellular neurobiology of depression. Nat Med 2011; 7: 541\u2013547.","journal-title":"Nat Med"},{"key":"BFtp201621_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28\u201340.","journal-title":"Am J Psychiatry"},{"key":"BFtp201621_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010; 329: 959\u2013964.","journal-title":"Science"},{"key":"BFtp201621_CR8","doi-asserted-by":"publisher","first-page":"e56053","DOI":"10.1371\/journal.pone.0056053","volume":"8","author":"XC Ma","year":"2013","unstructured":"Ma XC, Dang YH, Jia M, Ma R, Wang F, Wu J et al. Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in chronic mild stress model of mice. PLoS One 2013; 8: e56053.","journal-title":"PLoS One"},{"key":"BFtp201621_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","volume":"29","author":"W Zhou","year":"2014","unstructured":"Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ . Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Eur Psychiatry 2014; 29: 419\u2013423.","journal-title":"Eur Psychiatry"},{"key":"BFtp201621_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47: 351\u2013354.","journal-title":"Biol Psychiatry"},{"key":"BFtp201621_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63: 856\u2013864.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp201621_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","volume":"67","author":"N Diazgranados","year":"2010","unstructured":"Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S et al. A randomized add-on of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010; 67: 793\u2013802.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp201621_CR13","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","volume":"170","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 2013; 170: 1134\u20131142.","journal-title":"Am J Psychiatry"},{"key":"BFtp201621_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","volume":"61","author":"K Hashimoto","year":"2009","unstructured":"Hashimoto K . Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 2009; 61: 105\u2013123.","journal-title":"Brain Res Rev"},{"key":"BFtp201621_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1126\/science.1222939","volume":"338","author":"RS Duman","year":"2012","unstructured":"Duman RS, Aghajanian GK . Synaptic dysfunction in depression: potential therapeutic targets. Science 2012; 338: 68\u201372.","journal-title":"Science"},{"key":"BFtp201621_CR16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.biopsych.2013.03.026","volume":"73","author":"JH Krystal","year":"2013","unstructured":"Krystal JH, Sanacora G, Duman RS . Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry 2013; 73: 1133\u20131141.","journal-title":"Biol Psychiatry"},{"key":"BFtp201621_CR17","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00213-014-3543-0","volume":"231","author":"C Yang","year":"2014","unstructured":"Yang C, Hashimoto K . Rapid antidepressant effects and abuse liability of ketamine. Psychopharmacology (Berl) 2014; 231: 2041\u20132042.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp201621_CR18","first-page":"35","volume":"20C","author":"ET Kavalali","year":"2014","unstructured":"Kavalali ET, Monteggia LM . How dose ketamine elicit a rapid antidepressant response? Curr Opin Pharmacol 2014; 20C: 35\u201339.","journal-title":"Curr Opin Pharmacol"},{"key":"BFtp201621_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.conb.2014.12.004","volume":"30C","author":"LM Monteggia","year":"2015","unstructured":"Monteggia LM, Zarate C Jr . Antidepressant actions of ketamine: from molecular mechanisms to clinical practice. Curr Opin Neurobiol 2015; 30C: 139\u2013143.","journal-title":"Curr Opin Neurobiol"},{"key":"BFtp201621_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.neuropharm.2011.01.046","volume":"61","author":"M Egeland","year":"2011","unstructured":"Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P . Co-expression of serotonin 5-HT1B and 5-HT4 receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum. Neuropharmacology 2011; 61: 442\u2013450.","journal-title":"Neuropharmacology"},{"key":"BFtp201621_CR21","doi-asserted-by":"publisher","first-page":"11360","DOI":"10.1073\/pnas.1209293109","volume":"109","author":"JL Warner-Schmidt","year":"2012","unstructured":"Warner-Schmidt JL, Schmidt EF, Marshall JJ, Rubin AJ, Arango-Lievano M, Kaplitt MG et al. Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior. Proc Natl Acad Sci USA 2012; 109: 11360\u20131165.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp201621_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrn3564","volume":"14","author":"P Svenningsson","year":"2013","unstructured":"Svenningsson P, Kim Y, Warner-Schmidt J, Oh YS, Greengard P . p11 and its role in depression and therapeutic responses to antidepressants. Nat Rev Neurosci 2013; 14: 673\u2013680.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp201621_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.1117571","volume":"311","author":"P Svenningsson","year":"2006","unstructured":"Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M et al. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006; 311: 77\u201380.","journal-title":"Science"},{"key":"BFtp201621_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jpsychires.2010.08.012","volume":"45","author":"L Zhang","year":"2011","unstructured":"Zhang L, Su TP, Choi K, Maree W, Li CT, Chung MY et al. P11 (S100A10) as a potential biomarker of psychiatric patients at risk of suicide. J Psychiatr Res 2011; 45: 435\u2013441.","journal-title":"J Psychiatr Res"},{"key":"BFtp201621_CR25","first-page":"131","volume":"33","author":"H Anisman","year":"2008","unstructured":"Anisman H, Du L, Palkovits M, Faludi G, Kovacs GG, Szontagh-Kishazi P et al. Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. J Psychiatry Neurosci 2008; 33: 131\u2013141.","journal-title":"J Psychiatry Neurosci"},{"key":"BFtp201621_CR26","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.cell.2012.03.038","volume":"149","author":"EF Schmidt","year":"2012","unstructured":"Schmidt EF, Warner-Schmidt JL, Otopalik BG, Pickett SB, Greengard P, Heintz N . Identification of the cortical neurons that mediate antidepressant responses. Cell 2012; 149: 1152\u20131163.","journal-title":"Cell"},{"key":"BFtp201621_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011; 475: 91\u201395.","journal-title":"Nature"},{"key":"BFtp201621_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1017\/S1461145713001119","volume":"17","author":"CN Haile","year":"2014","unstructured":"Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A et al. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol 2014; 17: 331\u2013336.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp201621_CR29","doi-asserted-by":"publisher","first-page":"pii: pyu033","DOI":"10.1093\/ijnp\/pyu033","volume":"18","author":"AE Lepack","year":"2014","unstructured":"Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS . BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol 2014; 18: pii: pyu033.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp201621_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.biopsych.2010.04.029","volume":"68","author":"JL Warner-Schmidt","year":"2010","unstructured":"Warner-Schmidt JL, Chen EY, Zhang X, Marshall JJ, Morozov A, Svenningsson P et al. A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biol Psychiatry 2010; 68: 528\u2013535.","journal-title":"Biol Psychiatry"},{"key":"BFtp201621_CR31","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1172\/JCI43992","volume":"121","author":"M Cazorla","year":"2011","unstructured":"Cazorla M, Pr\u00e9mont J, Mann A, Girard N, Kellendonk C, Rognan D . Identification of a low\u2013molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J Clin Invest 2011; 121: 1846\u20131857.","journal-title":"J Clin Invest"},{"key":"BFtp201621_CR32","doi-asserted-by":"publisher","first-page":"e112683","DOI":"10.1371\/journal.pone.0112683","volume":"9","author":"HF Gu","year":"2014","unstructured":"Gu HF, Nie YX, Tong QZ, Tang YL, Zeng Y, Jing KQ et al. Epigallocatechin-3-gallate attenuates impairment of learning and memory in chronic unpredictable mild stress-treated rats by restoring hippocampal autophagic flux. PLoS One 2014; 9: e112683.","journal-title":"PLoS One"},{"key":"BFtp201621_CR33","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1038\/nprot.2012.099","volume":"7","author":"GM Beaudoin 3rd","year":"2012","unstructured":"Beaudoin GM 3rd, Lee SH, Singh D, Yuan Y, Ng YG, Reichardt LF et al. Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex. Nat Protoc 2012; 7: 1741\u20131754.","journal-title":"Nat Protoc"},{"key":"BFtp201621_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/FBP.0b013e3282ee2aa8","volume":"18","author":"HD Schmidt","year":"2007","unstructured":"Schmidt HD, Duman RS . The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 2007; 18: 391\u2013418.","journal-title":"Behav Pharmacol"},{"key":"BFtp201621_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pneurobio.2012.09.001","volume":"100","author":"K Hashimoto","year":"2013","unstructured":"Hashimoto K . Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Prog Neurobiol 2013; 100: 15\u201329.","journal-title":"Prog Neurobiol"},{"key":"BFtp201621_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1440-1819.2010.02113.x","volume":"64","author":"K Hashimoto","year":"2010","unstructured":"Hashimoto K . Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci 2010; 64: 341\u2013357.","journal-title":"Psychiatry Clin Neurosci"},{"key":"BFtp201621_CR37","first-page":"pyu077","volume":"18","author":"JC Zhang","year":"2014","unstructured":"Zhang JC, Wu J, Fujita Y, Yao W, Ren Q, Yang C et al. Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in the hippocampus and nucleus accumbens after inflammation. Int J Neuropsychopharmacol 2014; 18: pyu077.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp201621_CR38","doi-asserted-by":"publisher","first-page":"pyu121","DOI":"10.1093\/ijnp\/pyu121","volume":"18","author":"C Yang","year":"2015","unstructured":"Yang C, Shirayama Y, Zhang JC, Ren Q, Hashimoto K . Regional differences in brain-derived neurotrophic factor and dendritic spine density confer resilience to inescapable stress. Int J Neuropsychopharmacol 2015; 18: pyu121.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp201621_CR39","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrn1726","volume":"6","author":"B Lu","year":"2005","unstructured":"Lu B, Pang PT, Woo NH . The Yin and Yang of neurotrophin action. Nat Neurosci 2005; 6: 603\u2013614.","journal-title":"Nat Neurosci"},{"key":"BFtp201621_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12035-014-9013-1","volume":"53","author":"D Fan","year":"2015","unstructured":"Fan D, Li J, Zheng B, Hua L, Zuo Z . Enriched environment attenuates surgery-induced impairment of learning, memory, and neurogenesis possibly by preserving BDNF expression. Mol Neurobiol 2015; 53: 344\u2013354.","journal-title":"Mol Neurobiol"},{"key":"BFtp201621_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00213-013-3024-x","volume":"228","author":"V Gigliucci","year":"2013","unstructured":"Gigliucci V, O'Dowd G, Casey S, Egan D, Gibney S, Harkin A . Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. Psychopharmacology (Berl) 2013; 228: 157\u2013166.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp201621_CR42","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.neuroscience.2007.04.045","volume":"147","author":"G de Foubert","year":"2007","unstructured":"de Foubert G, O'Neill MJ, Zetterstr\u00f6m TS . Acute onset by 5-HT6-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression. Neuroscience 2007; 147: 778\u2013785.","journal-title":"Neuroscience"},{"key":"BFtp201621_CR43","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.pnpbp.2009.07.001","volume":"33","author":"A Tamburella","year":"2009","unstructured":"Tamburella A, Micale V, Navarria A, Drago F . Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 1205\u20131210.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp201621_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coph.2006.10.001","volume":"7","author":"P Svenningsson","year":"2007","unstructured":"Svenningsson P, Greengard P . p11 (S100A10)\u2014an inducible adaptor protein that modulates neuronal functions. Curr Opin Pharmacol 2007; 7: 27\u201332.","journal-title":"Curr Opin Pharmacol"},{"key":"BFtp201621_CR45","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1523\/JNEUROSCI.6382-10.2011","volume":"32","author":"J Winterer","year":"2011","unstructured":"Winterer J, Stempel AV, Dugladze T, F\u00f6ldy C, Maziashvili N, Zivkovic AR et al. Cell-type-specific modulation of feedback inhibition by serotonin in the hippocampus. J Neurosci 2011; 32: 8464\u20138475.","journal-title":"J Neurosci"},{"key":"BFtp201621_CR46","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1523\/JNEUROSCI.5343-08.2009","volume":"29","author":"JL Warner-Schmidt","year":"2009","unstructured":"Warner-Schmidt JL, Flajolet M, Maller A, Chen EY, Qi H, Svenningsson P et al. Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci 2009; 29: 1937\u20131946.","journal-title":"J Neurosci"},{"key":"BFtp201621_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/hipo.20156","volume":"16","author":"JL Warner-Schmidt","year":"2006","unstructured":"Warner-Schmidt JL, Duman RS . Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006; 16: 239\u2013249.","journal-title":"Hippocampus"},{"key":"BFtp201621_CR48","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1046\/j.1460-9568.1998.00248.x","volume":"10","author":"M Muramatsu","year":"1998","unstructured":"Muramatsu M, Lapiz MD, Tanaka E, Grenhoff J . Serotonin inhibits synaptic glutamate currents in rat nucleus accumbens neurons via presynaptic 5-HT1B receptors. Eur J Neurosci 1998; 10: 2371\u20132379.","journal-title":"Eur J Neurosci"},{"key":"BFtp201621_CR49","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","volume":"55","author":"G Lucas","year":"2007","unstructured":"Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S et al. Serotonin4 (5-HT4 receptor agonists are putative antidepressants with a rapid onset of action. Neuron 2007; 55: 712\u2013725.","journal-title":"Neuron"},{"key":"BFtp201621_CR50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E","volume":"36","author":"JM Garc\u00eda-Verdugo","year":"1988","unstructured":"Garc\u00eda-Verdugo JM, Doetsch F, Wichterle H, Lim DA, Alvarez-Buylla A . Architecture and cell types of the adult subventricular zone: in search of the stem cells. J Neurobiol 1988; 36: 234\u2013248.","journal-title":"J Neurobiol"},{"key":"BFtp201621_CR51","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.biopsych.2012.11.011","volume":"73","author":"JM Dwyer","year":"2013","unstructured":"Dwyer JM, Duman RS . Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants. Biol Psychiatry 2013; 73: 1189\u20131198.","journal-title":"Biol Psychiatry"},{"key":"BFtp201621_CR52","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.biopsych.2010.01.024","volume":"67","author":"M Egeland","year":"2010","unstructured":"Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P . Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice. Biol Psychiatry 2010; 67: 1048\u20131056.","journal-title":"Biol Psychiatry"},{"key":"BFtp201621_CR53","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","volume":"62","author":"DJ David","year":"2009","unstructured":"David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I et al. Neurogenesis-dependent and \u2013independent effects of fluoxetine in an animal model of anxiety\/depression. Neuron 2009; 62: 479\u2013493.","journal-title":"Neuron"},{"key":"BFtp201621_CR54","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","volume":"232","author":"JC Zhang","year":"2015","unstructured":"Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M et al. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. Psychopharmacology (Berl) 2015; 232: 4325\u20134335.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp201621_CR55","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.euroneuro.2015.09.002","volume":"25","author":"Y Shirayama","year":"2015","unstructured":"Shirayama Y, Yang C, Zhang JC, Ren Q, Yao W, Hashimoto K . Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist. Eur Neuropsychopharmacol 2015; 25: 2449\u20132458.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp201621_CR56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/bs.irn.2015.07.003","volume":"124","author":"EJ Nestler","year":"2015","unstructured":"Nestler EJ . Role of the brain\u2019s reward circuitry in depression: transcriptional mechanisms. Int Rev Neurobiol 2015; 124: 151\u2013170.","journal-title":"Int Rev Neurobiol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp201621.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201621","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201621.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:42:05Z","timestamp":1672821725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp201621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2]]}},"alternative-id":["BFtp201621"],"URL":"https:\/\/doi.org\/10.1038\/tp.2016.21","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]},"assertion":[{"value":"7 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KH is an inventor on a filed patent application (pending) on \u2018The use of R-ketamine in the treatment of psychiatric diseases\u2019 by Chiba University. KH has served as a scientific consultant to Astellas and Taisho, and he also received the research support from Abbvie, Dainippon Sumitomo, Otsuka and Taisho. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}